Cargando…

The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy

High grade chondrosarcoma is characterized by its lack of response to conventional cytotoxic chemotherapy, the tendency to develop lung metastases, and low survival rates. Research within the field prioritizes the development and expansion of new treatment options for dealing with unresectable or me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohberger, Birgit, Steinecker-Frohnwieser, Bibiane, Stuendl, Nicole, Kaltenegger, Heike, Leithner, Andreas, Rinner, Beate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158315/ https://www.ncbi.nlm.nih.gov/pubmed/27978543 http://dx.doi.org/10.1371/journal.pone.0168193

Ejemplares similares

Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation
por: Lohberger, Birgit, et al.
Publicado: (2015)

Effects of a combined therapy of bortezomib and ionizing radiation on chondrosarcoma three-dimensional spheroid cultures
por: Lohberger, Birgit, et al.
Publicado: (2021)

Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
por: Lohberger, Birgit, et al.
Publicado: (2022)

Sesquiterpene Lactones Downregulate G2/M Cell Cycle Regulator Proteins and Affect the Invasive Potential of Human Soft Tissue Sarcoma Cells
por: Lohberger, Birgit, et al.
Publicado: (2013)

Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes
por: Steinecker-Frohnwieser, Bibiane, et al.
Publicado: (2017)

Effect of Cyclic Mechanical Stimulation on the Expression of Osteogenesis Genes in Human Intraoral Mesenchymal Stromal and Progenitor Cells
por: Lohberger, Birgit, et al.
Publicado: (2014)

Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes
por: Lohberger, Birgit, et al.
Publicado: (2022)

Nuclear Magnetic Resonance Therapy Modulates the miRNA Profile in Human Primary OA Chondrocytes and Antagonizes Inflammation in Tc28/2a Cells
por: Steinecker-Frohnwieser, Bibiane, et al.
Publicado: (2021)

Activation of the Mechanosensitive Ion Channels Piezo1 and TRPV4 in Primary Human Healthy and Osteoarthritic Chondrocytes Exhibits Ion Channel Crosstalk and Modulates Gene Expression
por: Steinecker-Frohnwieser, Bibiane, et al.
Publicado: (2023)

Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines
por: Bernhart, Eva, et al.
Publicado: (2017)

The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
por: Lohberger, Birgit, et al.
Publicado: (2013)

Establishment of a novel cellular model for myxofibrosarcoma heterogeneity
por: Lohberger, Birgit, et al.
Publicado: (2017)

The Association of Blood Biomarkers and Body Mass Index in Knee Osteoarthritis: A Cross-Sectional Study
por: Schadler, Paul, et al.
Publicado: (2022)

CoCrMo surface modifications affect biocompatibility, adhesion, and inflammation in human osteoblasts
por: Lohberger, Birgit, et al.
Publicado: (2020)

Extended Ultrastructural Characterization of Chordoma Cells: The Link to New Therapeutic Options
por: Kolb, Dagmar, et al.
Publicado: (2014)

Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human Sarcoma
por: Lohberger, Birgit, et al.
Publicado: (2012)

Surface Modifications of Titanium Aluminium Vanadium Improve Biocompatibility and Osteogenic Differentiation Potential
por: Lohberger, Birgit, et al.
Publicado: (2021)

The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model
por: Lohberger, Birgit, et al.
Publicado: (2023)

The ATR Inhibitor VE-821 Enhances the Radiosensitivity and Suppresses DNA Repair Mechanisms of Human Chondrosarcoma Cells
por: Lohberger, Birgit, et al.
Publicado: (2023)

Results of an Inpatient Preventive Health Care Program to Improve Quality of Life, Psychosocial Health, and Work Ability in Austria
por: Thauerer, Bettina, et al.
Publicado: (2023)

The Patient’s Physiological Status at the Start Determines the Success of the Inpatient Cardiovascular Rehabilitation Program
por: Odrovicsné-Tóth, Anna, et al.
Publicado: (2023)

Cellular and Molecular Biological Alterations after Photon, Proton, and Carbon Ions Irradiation in Human Chondrosarcoma Cells Linked with High-Quality Physics Data
por: Lohberger, Birgit, et al.
Publicado: (2022)

Activation of efficient DNA repair mechanisms after photon and proton irradiation of human chondrosarcoma cells
por: Lohberger, Birgit, et al.
Publicado: (2021)

Enhanced Osteogenic Differentiation of Human Primary Mesenchymal Stem and Progenitor Cultures on Graphene Oxide/Poly(methyl methacrylate) Composite Scaffolds
por: Krukiewicz, Katarzyna, et al.
Publicado: (2020)

Heterologous Facilitation of G Protein-Activated K(+) Channels by β-Adrenergic Stimulation via Camp-Dependent Protein Kinase
por: Müllner, Carmen, et al.
Publicado: (2000)

Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure()
por: Pitcher, David S., et al.
Publicado: (2015)

The resistance mechanisms of proteasome inhibitor bortezomib
por: Lü, Shuqing, et al.
Publicado: (2013)

NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
por: Huang, Xi, et al.
Publicado: (2022)

Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies
por: Gellner, Verena, et al.
Publicado: (2016)

SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib
por: Kretschmer, Nadine, et al.
Publicado: (2022)

Comparative Gene Expression Analysis in WM164 Melanoma Cells Revealed That β-β-Dimethylacrylshikonin Leads to ROS Generation, Loss of Mitochondrial Membrane Potential, and Autophagy Induction
por: Kretschmer, Nadine, et al.
Publicado: (2018)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Chordoma Characterization of Significant Changes of the DNA Methylation Pattern
por: Rinner, Beate, et al.
Publicado: (2013)

Synthesis and Pharmacological In Vitro Investigations of Novel Shikonin Derivatives with a Special Focus on Cyclopropane Bearing Derivatives
por: Kretschmer, Nadine, et al.
Publicado: (2021)

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
por: Boccadoro, Mario, et al.
Publicado: (2005)

Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice
por: Yanaba, Koichi, et al.
Publicado: (2012)

Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
por: Gelman, Julia S., et al.
Publicado: (2013)

Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing
por: Fischer, Carina, et al.
Publicado: (2015)

Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
por: Yu, Hui-Chuan, et al.
Publicado: (2013)

Nuclear Magnetic Resonance Treatment Accelerates the Regeneration of Dorsal Root Ganglion Neurons in vitro
por: Mann, Anda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pg4j0pdscknndg2n2jpfoet59u